Do pathogens accelerate atherosclerosis?

Journal of Nutrition

Volumn 131, Issue 10, 2001, Pages

  Streblow, Daniel N ^a   Orloff, Susan L ^a   Nelson, Jay A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Chlamydia pneumonia; Human cytomegalovirus; Vascular disease

Indexed keywords

CHEMOKINE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ARTERY OCCLUSION; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE COURSE; EXPERIMENTAL MODEL; HERPES VIRUS; HUMAN; INFECTION; INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE;

EID: 0034785275     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/131.10.2798s     Document Type: Conference Paper

References (67)

1. Atherosclerosis and glycation
2. The registry of the International Society for Heart Transplantion: Sixth official report - 1989
3. Infections caused by Chlamydia pneumoniae strain TWAR
4. Atherosclerosis
5. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: The atherosclerosis risk in communities (ARIC) study
6. The link between CMV and atherosclerosis
7. The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis
8. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy
9. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease
10. The presence of CMV nucleic acids arterial walls of atherosclerotic and non-atherosclerotic patients
11. Cytomegalovirus antigen within human arterial smooth muscle cells
12. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis
13. Frequency of coexistence of cytomegalovirus and Chlamydia pneumoniae in atherosclerotic plaques
14. Cytomegalovirus genome and the immediate-early antigen in cells of different layers of human aorta
15. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques
16. Detection of Chlamydia pneumoniae in arterial tissues
17. Chlamydia pneumoniae in atherosclerotic tissue
18. Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue
19. Great amount of C. pneumoniae in ruptured plaque vessel segments at autopsy. A comparative study with stable plaques
20. Herpes-virus-induced atherosclerosis in chickens
21. Virus-induced atherosclerosis
22. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
23. Atherosclerosis in apoE knockout mice infected with multiple pathogens
24. Cytomegalovirus infection increases neointimal formation in the rat model of balloon injury
25. Enhancement of transplantation associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC
26. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection
27. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts
28. Elimination of donor-specific alloreactivity by bone marrow chimerism prevents cytomegalovirus accelerated transplant vascular sclerosis in rat small bowel transplants
29. A rat small bowel transplant model of chronic rejection: Histopathologic characteristics
30. De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model
31. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
32. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis
33. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits
34. Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice
35. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae
36. Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice
37. Altered cholesteryl ester cycle is associated with lipid accumulation in herpesvirus-infected arterial smooth muscle cells
38. Herpesvirus infection enhances cholesterol and cholesteryl ester accumulation in cultured arterial smooth muscle cells
39. Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells
40. Chlamydia, inflammation, and atherogenesis
41. Induction of endothelial adhesion molecules by rat cytomegalovirus in allogeneic lung transplantation in the rat
42. Interactions of Chlamydia pneumoniae with human endothelial cells
43. Altered production of GM-CSF and IL-8 in cytomegalovirus-infected, IL-1-primed umbilical cord endothelial cells
44. The procoagulant response of cytomegalovirus infected endothelial cells
45. Human cytomegalovirus IE1 and IE2 proteins block apoptosis
46. Strain specific effects of cytomegalovirus on endothelial cells: Implications for investigating the relationship between CMV and cardiac allograft vasculopathy
47. The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor
48. Modulation of RANTES production by human cytomegalovirus infection of fibroblasts
49. Vascular smooth muscle cell migration is induced by the human cyteomegalovirus chemokine receptor US28
50. Chemokines
51. Monocyte chemoattractant protein-1 in human atheromatous plaques
52. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
53. RANTES chemokine expression in cell-mediated transplant rejection of the kidney
54. Decreased lesion formation in CCR2 -/- mice reveals a role for chemokines in the initiation of atherosclerosis
55. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
56. Chemokines and atherosclerosis
57. Sequential cytokine dynamics in chronic rejection of rat renal allografts: Roles for cytokines RANTES and MCP-1
58. Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts
59. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169
60. The DNA sequence of human herpesvirus-6: Structure, coding content, and genome evolution
61. Human cytomegalovirus encodes three G protein-coupled receptor homologues
62. Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection
63. Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescence protein gene
64. The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection
65. Identification and characterization of a G protein-coupled receptor homolog endcoded by murine cytomegalovirus
66. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: Withdrawal of chemokines from the environment of cytomegalovirus-infected cells